INBX – inhibrx, inc. (US:NASDAQ)

News

Best Quant-rated small- and mid-cap healthcare stocks as LLY hits $1T in market cap [Seeking Alpha]
Inhibrx Biosciences (NASDAQ:INBX) had its "market perform" rating reaffirmed by analysts at Citigroup Inc..
Inhibrx Biosciences GAAP EPS of -$2.28 [Seeking Alpha]
Inhibrx Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
Inhibrx Reports Third Quarter 2025 Financial Results
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com